Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 5 de 5
Filter
Add more filters










Database
Language
Publication year range
1.
Waste Manag ; 30(6): 1018-24, 2010 Jun.
Article in English | MEDLINE | ID: mdl-20211554

ABSTRACT

The use of biomass and waste to produce alternative fuels, due to environmental and energy security reasons, is a high-quality solution especially when integrated with high efficiency fuel cell applications. In this article we look into the coupling of an anaerobic digestion process of organic residues to electrochemical conversion to electricity and heat through a molten carbonate fuel cell (MCFC). In particular the pathway of the exceedingly harmful compound hydrogen sulphide (H(2)S) in these phases is analysed. Hydrogen sulphide production in the biogas is strongly interrelated with methane and/or hydrogen yield, as well as with operating conditions like temperature and pH. When present in the produced biogas, this compound has multiple negative effects on the performance and durability of an MCFC. Therefore, there are important issues of integration to be solved. Three general approaches to solve the sulphur problem in the MCFC are possible. The first is to prevent the formation of hydrogen sulphide at the source: favouring conditions that inhibit its production during fermentation. Secondly, to identify the sulphur tolerance levels of the fuel cell components currently in use and develop sulphur-tolerant components that show long-term electrochemical performance and corrosion stability. The third approach is to remove the generated sulphur species to very low levels before the gas enters the fuel cell.


Subject(s)
Conservation of Energy Resources , Hydrogen Sulfide/metabolism , Bacteria, Anaerobic , Biofuels , Biomass , Carbon/metabolism , Electricity , Organic Chemicals/metabolism
2.
J Lipid Res ; 50(4): 658-66, 2009 Apr.
Article in English | MEDLINE | ID: mdl-19017617

ABSTRACT

The fungal pathogen Candida albicans transforms arachidonic acid (AA) into 3-hydroxyarachidonic acid [3R-HETE], and we investigated if its nonpathogenic and 3R-HETE-producing close relative, Dipodascopsis uninucleata, could similarly transform the endocannabinoid/endovanilloid anandamide into 3-hydroxyanandamide (3-HAEA). We found that D. uninucleata converts anandamide into 3-HAEA, and we therefore developed an enantiodivergent synthesis for this compound to study its pharmacological activity. Both enantiomers of 3-HAEA were as active as anandamide at elevating intracellular Ca2+ via TRPV1 receptors overexpressed in HEK-293 cells, while a approximately 70-90-fold and approximately 45-60-fold lower affinity at cannabinoid CB1 and CB2 receptors was instead observed. Patch clamp recordings showed that 3R-HAEA activates a TRPV1-like current in TRPV1-expressing HEK-293 cells. Thus, 3R-HETE-producing yeasts might convert anandamide released by host cells at the site of infection into 3R-HAEA, and this event might contribute to the inflammatory and algogenous responses associated to fungal diseases.


Subject(s)
Arachidonic Acids/biosynthesis , Arachidonic Acids/chemical synthesis , Polyunsaturated Alkamides/chemical synthesis , Saccharomycetales/metabolism , Arachidonic Acid/metabolism , Arachidonic Acids/chemistry , Arachidonic Acids/pharmacology , Cell Line , Endocannabinoids , Humans , Hydroxyeicosatetraenoic Acids/metabolism , Mycoses/etiology , Mycoses/metabolism , Mycoses/microbiology , Patch-Clamp Techniques , Polyunsaturated Alkamides/chemistry , Polyunsaturated Alkamides/pharmacology , Receptor, Cannabinoid, CB1/metabolism , Receptor, Cannabinoid, CB2/metabolism , Recombinant Proteins/metabolism , Saccharomycetales/pathogenicity , Stereoisomerism , TRPV Cation Channels/metabolism
3.
Article in English | MEDLINE | ID: mdl-17997296

ABSTRACT

The 12S-lipoxygenase (12S-LOX) pathway of arachidonic acid (AA) metabolism is bifurcated at 12(S)-hydroperoxy-5Z,8Z,10E (12S-HpETE) in the reduction route to form 12S-hydroxy-eicosatetraenoic acid (12S-HETE) and in 8(S/R)-hydroxy-11(S),12S-trans-epoxyeicosa-5Z,9E,14Z-trienoic acid (HXA3) synthase pathway, previously known as isomerization route, to form hepoxilins. Earlier we showed that the HXA3 formation is restricted to cellular systems devoid of hydroperoxide reducing enzymes, e.g. GPxs, thus causing a persistent oxidative stress situation. Here, we show that HXA3 at as low as 100 nM concentration upregulates phospholipid hydroperoxide glutathione peroxidase (PHGPx) mRNA and protein expressions, whereas other metabolites of AA metabolism 12S-HpETE and 12S-HETE failed to stimulate the PHGPx. Moreover, the decrease in 12S-HpETE below a threshold value of the hydroperoxide tone causes both suppression of the overall 12S-LOX activity and a shift from HXA3 formation towards 12S-HETE formation. We therefore propose that under persistent oxidative stress the formation of HXA3 and the HXA3-induced upregulation of PHGPx constitute a compensatory defense response to protect the vitality and functionality of the cell.


Subject(s)
8,11,14-Eicosatrienoic Acid/analogs & derivatives , Glutathione Peroxidase/metabolism , Oxidative Stress/physiology , 8,11,14-Eicosatrienoic Acid/metabolism , Animals , Cells, Cultured , Phospholipid Hydroperoxide Glutathione Peroxidase , RNA, Messenger/metabolism , Rats , Up-Regulation
4.
FEMS Microbiol Lett ; 198(1): 37-43, 2001 Apr 20.
Article in English | MEDLINE | ID: mdl-11325551

ABSTRACT

3(R)-Hydroxyoxylipins are produced via an aspirin-sensitive pathway in Candida albicans, an abundant pathogen in vulvovaginal candidiasis. In the present study, we have investigated the effect of aspirin on vaginal isolates of C. albicans from patients with recurrent candidiasis. Aspirin alone and with clotrimazole, a commonly used drug, strongly suppressed growth of C. albicans. 3(R)-Hydroxyoxylipins, which were selectively located in hyphae and other filamentous structures, but not in free blastospores, were almost totally suppressed by aspirin. Moreover, C. albicans stimulated prostaglandin E(2) (PGE(2)) production in HeLa cells. PGE(2) is a stimulus for germ tube formation in C. albicans. We conclude therefore that the administration of aspirin should be beneficial in the treatment of vulvovaginal candidiasis by dual ways: (i) by inhibition of 3(R)-hydroxyoxylipin formation, and (ii) by inhibition of PGE(2) formation in the infected host tissue.


Subject(s)
Arachidonic Acids/pharmacology , Aspirin/pharmacology , Candida albicans/drug effects , Candidiasis, Vulvovaginal/microbiology , Antifungal Agents/pharmacology , Candida albicans/growth & development , Candida albicans/metabolism , Clotrimazole/pharmacology , Dinoprostone/biosynthesis , Female , HeLa Cells , Humans , Microscopy, Fluorescence , Recurrence
5.
Biochim Biophys Acta ; 1486(2-3): 299-311, 2000 Jul 19.
Article in English | MEDLINE | ID: mdl-10903481

ABSTRACT

Infection of human tissues by Candida albicans has been reported to cause the release of arachidonic acid (AA), eicosanoids and other proinflammatory mediators from host cells. Therefore, we investigated the interaction of this pathogen with AA. AA stimulated cell growth at micromolar concentrations when used as a sole carbon source. Moreover, it selectively inhibited the antimycin A-resistant alternative oxidase. [1-(14)C]AA was completely metabolised by C. albicans. Only one-seventh of the radioactivity metabolised was found in CO(2), whereas two-thirds occurred in carbohydrates suggesting a predominant role of the glyoxalate shunt of citrate cycle. About 1% of radioactivity was found in polar lipids including eicosanoids. A novel AA metabolite, which revealed immunoreactivity with an antibody against 3(R)-hydroxy-oxylipins, was identified as 3, 18-dihydroxy-5,8,11,14-eicosatetraenoic acid. Using immunofluorescence microscopy, endogenous 3(R)-hydroxy-oxylipins were found in hyphae but not in yeast cells. Such compounds have recently been shown to be connected with the sexual stage of the life cycle of Dipodascopsis uninucleata. Together, we propose that infection-mediated release of AA from host cells may modulate cell growth, morphogenesis and invasiveness of C. albicans by several modes. A better understanding of its role is thus promising for novel approaches towards the treatment of human mycoses.


Subject(s)
Arachidonic Acid/pharmacology , Candida albicans/drug effects , Arachidonic Acid/metabolism , Candida albicans/growth & development , Candida albicans/metabolism , Carbon Radioisotopes , Cell Division/drug effects , Gas Chromatography-Mass Spectrometry , Hydroxyeicosatetraenoic Acids/metabolism , Linoleic Acid/pharmacology , Microscopy, Fluorescence , Mitochondrial Proteins , Oxidoreductases/antagonists & inhibitors , Plant Proteins , Salicylic Acid/pharmacology
SELECTION OF CITATIONS
SEARCH DETAIL
...